Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy-Reference-Cited by-同舟云学术

Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy

Published:2020-02-19 Issue:5 Volume:153 Page:650-661
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Kessler Tobias¹²,Latzer Pauline²,Schmid Dominic²³,Warnken Uwe⁴,Saffari Afshin⁵,Ziegler Andreas⁵,Kollmer Jennifer⁶,Möhlenbruch Markus⁶,Ulfert Christian⁶,Herweh Christian⁶,Wildemann Brigitte¹,Wick Wolfgang¹²,Weiler Markus¹^ORCID

Affiliation:

1. Department of Neurology Heidelberg University Hospital Heidelberg Germany

2. Clinical Cooperation Unit Neurooncology German Cancer Consortium (DKTK) German Cancer Research Center (DKFZ) Heidelberg Germany

3. Medical Faculty University of Heidelberg Heidelberg Germany

4. Functional Proteomic Analysis German Cancer Research Center (DKFZ) Heidelberg Germany

5. Division of Child Neurology and Metabolic Medicine Center for Child and Adolescent Medicine Heidelberg University Hospital Heidelberg Germany

6. Department of Neuroradiology Heidelberg University Hospital Heidelberg Germany

Funder

Deutsches Krebsforschungszentrum

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.14953

Reference37 articles.

1. Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure

2. Expression of DJ-1 in Neurodegenerative Disorders

3. Pharmacology of Antisense Drugs

4. Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS

5. Collagen Type VI Myopathies

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy;Cellular and Molecular Life Sciences;2024-09-10

2. Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis;Neurology and Therapy;2024-09-02

3. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

4. A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2024-03-27

5. Study of nusinersen metabolites in the cerebrospinal fluid of children with spinal muscular atrophy using ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry;The Analyst;2024